Real-Options Valuation for a Biotechnology Company
- 1 May 2000
- journal article
- Published by Taylor & Francis in CFA Magazine
- Vol. 56 (3) , 76-84
- https://doi.org/10.2469/faj.v56.n3.2362
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A market utility approach to investment valuationEuropean Journal of Operational Research, 1994
- Returns to R&D on new drug introductions in the 1980sJournal of Health Economics, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- Option pricing: A simplified approachJournal of Financial Economics, 1979